Volume 24, Issue 1 | Osteoporosis International

Search all Osteoporosis International articles

Volume 24, Issue 1

January 2013

Filter by

Volume:

Sort by

Date published:

New to old Old to new

41 articles in this issue

The effect of treatments for osteoporosis on mortality
A. Grey
M. J. Bolland
Review 18 October 2012 Pages: 1 - 6
Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis
J. Martínez-Mesa
M. C. Restrepo-Méndez
A. M. B. Menezes
Review 29 August 2012 Pages: 7 - 18
Erratum to: Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis
J. Martínez-Mesa
M. C. Restrepo-Méndez
A. M. B. Menezes
Erratum 28 September 2012 Pages: 19 - 21
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis
E. V. McCloskey
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF)
Position Paper Open access 19 October 2012 Pages: 23 - 57
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
G. Ioannidis
J. Flahive
for the GLOW Investigators
Original Article 12 April 2012 Pages: 59 - 67
Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women
S. Tanaka
T. Kuroda
M. Shiraki
Original Article 15 November 2012 Pages: 69 - 76
Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study
S. Boutroy
D. Hans
R. Chapurlat
Original Article 16 October 2012 Pages: 77 - 85
Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men
S. Verschueren
E. Gielen
S. Boonen
Original Article 10 July 2012 Pages: 87 - 98
A decreasing trend in fall-related hip fracture incidence in Victoria, Australia
E. Cassell
A. Clapperton
Original Article 21 February 2012 Pages: 99 - 109
Depressive symptoms and rates of bone loss at the hip in older men
S. J. Diem
S. L. Harrison
for the Osteoporotic Fractures in Men (MrOS) Research Group
Original Article 30 March 2012 Pages: 111 - 119
Relationship between use of antidepressants and risk of fractures: a meta-analysis
V. Rabenda
D. Nicolet
J.-Y. Reginster
Original Article 26 May 2012 Pages: 121 - 137
Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products
F. J. B. Lötters
I. Lenoir-Wijnkoop
M. J. Poley
Original Article Open access 16 June 2012 Pages: 139 - 150
Cost-effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial
C. E. Wyers
P. L. M. Reijven
P. C. Dagnelie
Original Article Open access 26 May 2012 Pages: 151 - 162
Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight
J. T. Schousboe
M. Gourlay
For the Osteoporotic Fractures in Men (MrOS) and Study of Osteoporotic Fractures (SOF) Research Groups
Original Article 17 February 2012 Pages: 163 - 177
Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study
H. P. Bhattoa
E. Nagy
P. Antal-Szalmas
Original Article 16 March 2012 Pages: 179 - 186
Vitamin D status is associated with physical performance: the results of three independent cohorts
E. Sohl
R. T. de Jongh
N. M. van Schoor
Original Article 08 September 2012 Pages: 187 - 196
Vitamin D₂ from light-exposed edible mushrooms is safe, bioavailable and effectively supports bone growth in rats
M. S. Calvo
U. S. Babu
S. Nagaraja
Original Article 23 February 2012 Pages: 197 - 207
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
N. Freemantle
C. Cooper
C. Roux
Original Article 26 July 2012 Pages: 209 - 217
Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
M. Shiraki
T. Sugimoto
T. Nakamura
Original Article Open access 24 October 2012 Pages: 219 - 226
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
M. R. McClung
E. M. Lewiecki
P. D. Miller
Original Article Open access 10 July 2012 Pages: 227 - 235
Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges
D. H. Solomon
E. Mercer
N. Treister
Original Article 16 June 2012 Pages: 237 - 244
Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study
L. Bondo
P. Eiken
B. Abrahamsen
Original Article 26 May 2012 Pages: 245 - 252
A meta-analysis characterizing the dose–response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women
J. Yates
Original Article 26 October 2012 Pages: 253 - 262
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
T. Thomas
S. Horlait
J. L. Lange
Original Article 27 June 2012 Pages: 263 - 269
Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
J.-H. Kang
J. J. Keller
H.-C. Lin
Original Article 14 November 2012 Pages: 271 - 277
Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies
K. Sun
J. M. Liu
G. Ning
Original Article 06 October 2012 Pages: 279 - 286
QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis
J. K. Lee
C. H. Lee
C. H. Choi
Original Article 23 February 2012 Pages: 287 - 292
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
M. R. McClung
J. R. Zanchetta
P. Delmas
Original Article Open access 30 June 2012 Pages: 293 - 299
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
M. R. McClung
A. Balske
R. R. Recker
Original Article Open access 19 October 2012 Pages: 301 - 310
Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trial
R. D. Chapurlat
M. Laroche
M.-C. de Vernejoul
Original Article 09 March 2012 Pages: 311 - 320
Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study
B. Abrahamsen
K. H. Rubin
R. Eastell
Original Article 16 October 2012 Pages: 321 - 328
Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial
L. Yang
A. V. Sycheva
R. Eastell
Original Article 06 November 2012 Pages: 329 - 338
Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients
S. Gamsjaeger
B. Hofstetter
E. P. Paschalis
Original Article 15 November 2012 Pages: 339 - 347
The impact of dietary calcium intake and vitamin D status on the effects of zoledronate
S. Bourke
M. J. Bolland
I. R Reid
Original Article 15 August 2012 Pages: 349 - 354
Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis
A. Svedbom
L. Alvares
O. Ström
Original Article 14 August 2012 Pages: 355 - 367
Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database
B. Abrahamsen
Short Communication 10 May 2012 Pages: 369 - 372
Ten-year hip fracture incidence rate trends in a large California population, 1997–2006
A. L. Adams
J. Shi
S. J. Jacobsen
Short Communication 21 February 2012 Pages: 373 - 376
Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients
S. Pilz
A. Meinitzer
A. Fahrleitner-Pammer
Short Communication 17 March 2012 Pages: 377 - 381
The cyclooxygenase-2 selective inhibitor NS-398 does not influence trabecular or cortical bone gain resulting from repeated mechanical loading in female mice
T. Sugiyama
L. B. Meakin
J. S. Price
Short Communication Open access 14 February 2012 Pages: 383 - 388
Comment on Kanis et al.: Pitfalls in the external validation of FRAX
M. J. Bolland
A. Grey
I. R. Reid
Letter 15 May 2012 Pages: 389 - 390
Pitfalls in the external validation of FRAX: response to Bolland et al.
J. A. Kanis
A. Oden
E. McCloskey
Letter 15 May 2012 Pages: 391 - 392